Keller adds his colours to Spectrum as COO
This article was originally published in Scrip
Spectrum Pharmaceuticals has appointed Ken Keller its chief operating officer. Prior to joining Spectrum, Mr Keller spent 21 years at Amgen. His most recent role was vice-president and general manager, bone health business unit.